Mark Linch - Concepedia

Author

Mark Linch

Also Known As

Gert Attard, Javier Rico López, Linch, M, Linch, MD, Linch, Mark, M Linch, M. D. Linch, M. Linch, Mark D. Linch, Mark David Linch

162

Publications

Citations

H-Index

Concepts

All Affiliations

University College London Royal Marsden Hospital Royal Marsden NHS Foundation Trust London Cancer Queen Mary University of London

About

Mark Linch is an author at University College London specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.5K
2	Health Sciences	4	4	159
3	Natural Sciences	2	2	139
4	Management	1	1	41
5	Biochemistry	1	1	55

Mark Linch

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida, Nature Medicine UrologyBiomarker AnalysisGenitourinary CancerMedicineCancer Treatment	2019	555
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder Bernadett Szabados, Mark Kockx, Zoe J. Assaf, European Urology UrologyGenitourinary CancerMuscle-invasive Urothelial CancerMedicineCancer Treatment	2022	175
Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer Bernadett Szabados, Nick van Dijk, Yen Zhi Tang, European Urology Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineImmunology	2017	132
A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). Thomas Powles, Alejo Rodríguez‐Vida, Ignacio Durán, Journal of Clinical Oncology UrologySurgical OncologyTumoral PathologyPd-l1 InhibitorGenitourinary Cancer	2018	90
Control of MT1-MMP transport by atypical PKC during breast-cancer progression Carine Rossé, Catalina Lodillinsky, Laetitia Fuhrmann, Proceedings of the National Academy of Sciences	2014	88
mTORC2 targets AGC kinases through Sin1-dependent recruitment Angus J.M. Cameron, Mark Linch, Adrian T. Saurin, Biochemical Journal Molecular RegulationMolecular BiologyCellular PhysiologySignaling PathwayCell Regulation	2011	84
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study Evan Y. Yu, Michael Kolinsky, William L. Berry, European Urology	2022	76
aPKC Inhibition by Par3 CR3 Flanking Regions Controls Substrate Access and Underpins Apical-Junctional Polarization Erika Soriano, Marina E. Ivanova, Georgina Fletcher, Developmental Cell	2016	72
Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma Juan Martín-Liberal, Salma Alam, Anastasia Constantinidou, Sarcoma Myxoid/round-cell LiposarcomaSurgical OncologySoft-tissue Sarcoma14-Day Continuous InfusionMalignant Disease	2013	64
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters Mark Linch, Gerald Goh, Crispin T. Hiley, Annals of Oncology	2017	62

Page 1